Sales of analgesics slow down in 2021, following the boom seen in 2020 due to concerns about COVID-19. Consumers were driven to stockpiling in the first quarter of 2020, through fears they may be unable to obtain medicines if they should need them.
Basic options and low-cost brands continue to be in high demand in the country, for example as seen with paracetamol, ibuprofen and aceclofenac (Analgin). Such products are basic and affordable analgesics, albeit highly effective.
Pro Med CS Praha as maintains its lead in the fragmented category of analgesics in 2021, whilst the largest shares are held by “others”. This is thanks to the popularity of its Dolgit Cream, due to the product’s competitive price, long history and proven record of effectiveness in the country.
Analgesics is expected to bounce back into healthier growth over the forecast period, albeit not at the boosted rates seen in 2020. Although purchasing power in the country remains rather low, there is potential in terms of consumer base size, the quite visible growth of GDP and, consequently, the improving situation with real incomes.
Birth rates are expected to remain comparably high in Uzbekistan during the forecast period. Therefore, in line with the anticipated sustainable economic growth, the sales of paediatric analgesics are set to be dynamic over the forecast period.
Acetaminophen is expected to remain a notable category over the forecast period, as it offers a selection of affordable generic products which are very popular among low-income consumers. Overall, acetaminophen is a traditionally used and widely recognised product in Uzbekistan, and it also has a wide range of applications.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Analgesics industry in Uzbekistan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Uzbekistan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).See All of Our Definitions
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!